November 2023 Scholarly Communications Round-up

Learn more about the recommendations from ICJME for authors and AI, the Highly Cited Researchers list for 2023, the new Article Development Charge from the American Chemical Society, and a new video that helps researchers assess journal quality.

Authors and AI

The ICJME Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals Recommendations, May 2023, included guidance for authors using Artificial Intelligence (AI) for their works. Authors should describe in the cover letter and the submitted work how they used AI assisted technologies such as Large Language Models (LLM) or chatbots in the production of the work. In addition, authors should not list AI as an author or co-author as AI cannot be responsible for the accuracy, integrity, and originality of the work, which are required for authorship.

The Highly Cited Researchers™ list for 2023 from Clarivate™

The Highly Cited Researchers list for 2023 from Clarivate was released in November 2023. The list identifies authors who have demonstrated significant influence through publication of multiple highly cited papers that rank in the top 1% for field and publication year over an 11-year period, 2012 to 2022. Of the approximately 7,125 authors identified for the list for 2023, over 50 are from Washington University. Some authors were noted for exceptional performance in several fields.

For more information:

Article Development Charge (ADC) from the American Chemical Society (ACS)

Have you heard of the new Article Development Charge (ADC) from the American Chemical Society (ACS)? ACS recently announced an Article Development Charge (ADC), not an Article Processing Charge (APC), for “zero-embargo green open access.” The fee is $2,500. In plain language this means that authors will have to pay the ACS $2,500 for the right to post their final, peer-reviewed manuscript, not the final published version, in a repository per federal funding policies, with a zero embargo. It is universally understood per copyright law that authors retain the rights to their final, peer-reviewed manuscripts, and that no fee of any type is required for compliance with the current NIH Policy.

Responses to the ACS proposal:

Think. Check. Submit.

Think. Check. Submit. released a new video (1.44) that outlines key steps and considerations to help researchers assess whether a journal or publisher is suitable for their research.


Hwang SY, Yon DK, Lee SW, Kim MS, Kim JY, Smith L, Koyanagi A, Solmi M, Carvalho AF, Kim E, Shin JI, Ioannidis JPA. Causes for Retraction in the Biomedical Literature: A Systematic Review of Studies of Retraction Notices. J Korean Med Sci. 2023 Oct 23;38(41):e333. doi: 10.3346/jkms.2023.38.e333. PMID: 37873630.

Cochran A. Worth the Time? A Critical Look at the Value of Twitter for Journals. The Scholarly Kitchen. October 19, 2023.

Gotschall T, Spencer A, Hoogland MA, Cortez E, Irish E. Journals accepting case reports. 2023 Oct 2; 111(4): 819-822. doi: 10.5195/jmla.2023.1747. PMID: 37928130.

View or download the list at

Willis JV, Cobey KD, Ramos J, Chow R, Ng JY, Alayche M, Moher D. Limited online training opportunities exist for scholarly peer reviewers. J Clin Epidemiol. 2023 Sep;161:65-74. doi:10.1016/j.jclinepi.2023.06.023. PMID: 37421994.

Kiermer V. Authorship practices must evolve to support collaboration and open science. PLoS Biol. 2023 Oct 13;21(10): e3002364. doi:10.1371/journal.pbio.3002364. PMID: 37831717.

Lauer M. Case Study in Research Integrity: This Application Feels Familiar. NIH Extramural Nexus. November 21, 2023.

White House Office of Science and Technology Policy. Report to Congress on Financing Mechanisms For Open Access Publishing of Federally Funded Research. November 2023.

Mervis J. Proposed changes to rules for policing fraud in U.S.-funded biomedical research draw a mixed response. ScienceInsider. November 28, 2023.